Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 25, 2007

Investigators Identify 28 Genes Required for Silencing Proapoptotic Gene in Oncology

  • University of Massachusetts Medical School researchers say that they have identified 28 genes required for the activation of a cancer promoting pathway.

    The investigators performed a genome-wide RNAi screen in K-ras-transformed NIH 3T3 cells. They discovered these genes, which they believe are necessary for ras-mediated epigenetic silencing of the Fas, a proapoptotic gene silenced in certain cancers.

    They also report finding that at least nine of the 28 genes including the DNA methyltransferase DNMT1 are associated with specific regions of the Fas promoter in transformed cells but not in untransformed cells. Silencing any of these genes prevented DNMT1 from binding to the Fas promoter region and initiating hypermethylation, which resulted in restoration of Fas expression, the scientists note.

    Of the 28 genes involved in the pathway, nine of them are required for anchorage-independent growth and tumorigenicity of K-ras-transformed cells, according to the team.

    The study was published in the October 25 issue of Nature

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »